275
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Corneal Densitometry after Femtosecond Laser-Assisted In Situ Keratomileusis (Fs-LASIK) and Small Incision Lenticule Extraction (SMILE)

, , , , , , & show all
Pages 605-610 | Received 24 Jul 2017, Accepted 14 Jan 2018, Published online: 14 Mar 2018
 

ABSTRACT

Purpose: To compare corneal densitometry values after Femtosecond Laser-Assisted In Situ Keratomileusis (Fs-LASIK) and Small Incision Lenticule Extraction (SMILE) using Scheimpflug Imaging.

Methods: Our retrospective clinical trial included a total of 146 eyes where 57 eyes underwent Fs-LASIK and 89 eyes underwent SMILE. Examinations with a Pentacam Scheimpflug device (Oculus, Wetzlar, Germany) were performed before surgery, 1 week, 1 month, 3 months, 6 months, and 1 year after surgery. Detailed data of all four concentric optical zones were acquired – central 0–2 mm, 2–6 mm, 6–10 mm and 10–12 mm. The cornea was divided into anterior 120 µm, middle and posterior 60 µm sections. Values were analyzed during follow-up comparing Fs-LASIK and SMILE.

Results: No statistically significant differences in corneal density were detected. The central 0–2 mm anterior area demonstrated a mean 1-year value of 17.99 grayscale units (GSU) ± 0.89 (range 16.60–19.50) after Fs-LASIK versus 17.96 GSU ± 0.98 (range 16.40–20.00) after SMILE. Three months after surgery there was a slight temporary density increase in the 6–10 mm anterior annulus in the LASIK group – 22.19 (SD = 3.99, range: 15.60–30.50) compared to SMILE – 20.39 (SD = 3.79, range 14.70–36.30).

Conclusion: There were no statistically significant short or long-term differences in postoperative corneal densitometry after LASIK and SMILE, demonstrating SMILE is not inferior in this regard. Known delayed visual acuity recovery after SMILE in relation to LASIK could not be correlated with changes in corneal density.

Conflict of interest

All authors certify that there is no conflict of interest to be disclosed.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Financial Disclosure

Mehdi Shajari: Consultant: Oculus; Emanuel Wanner: None; Vladimir Rusev: None; Shervin Mir Mohi Sehfat: None; Wolfgang J. Mayer: Consultant or Advisory Board: Zeiss Meditec, Alcon, Ziemer, Polytech/Domilens, Allergan; Thomas Kohnen: Research Funding - Hoya, J&J Vision (Abbott), Novartis (Alcon), Oculentis, Oculus, Schwind, Zeiss; Consultant or Advisory Board - Geuder, J&J Vision (Abbott), Novartis (Alcon), Oculus, Santen, Schwind, STAAR, TearLab, Thea Pharma, Thieme Compliance, Ziemer, Zeiss; Siegfried Priglinger: Alcon, Polytech/Domilens, Örtli, Novartis, Zeiss; Daniel Kook: Consultant: Alcon, Zeiss Meditec

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 555.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.